Trials / Unknown
UnknownNCT02986295
Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent
Real World Drug-Eluting Stent Prospective, Open, Multi-site, Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent By SMart Angioplastry Research Team (SMARTDESK-MX)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Hyeon-Cheol Gwon · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent
Detailed description
A prospective, open, multicenter, and observational study will register and compare Xience® groups treated in institutions such as the BioMime ™, Ultimaster® group prospectively registered from June 2016. The Xience® group has already been registered in the previous study (SMARTDESK-BX), so BioMimeTM and Ultimaster® only need to be registered. Follow-up will be conducted until December 2019, and e-CRF will be completed by April 2020.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BioMimeTM Stent, Ultimaster® Stent |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2019-01-31
- Completion
- 2021-01-31
- First posted
- 2016-12-08
- Last updated
- 2018-02-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02986295. Inclusion in this directory is not an endorsement.